SLINTEC commercialises a record 8 patents and innovations within 12 months.

The Sri Lanka Institute of Nanotechnology (SLINTEC) witnessed a remarkable transformation – with four [04] patents having been commercialised, with an additional four [04] innovations in the advanced stage of commercialisation. Under the leadership of – Mr Thilan Wijesinghe, Investment Banker and PPP Specialist who took over as Chairman of SLINTEC in September 2022, and CEO Dr Thushara Vajera Perera (formerly a Senior Scientist at Pfizer Inc., USA, and Director – Innovation Health Science and Technology at MAS, Sri Lanka), SLINTEC has propelled forward towards global recognition, financial self-sufficiency, and groundbreaking contributions to Sri Lanka’s industrial innovation landscape.

Prior to the leadership transition at SLINTEC in 2023, over its 16-year history since its establishment in 2008, the institution had commercialised approximately seven [07] patents and innovations, averaging fewer than two [02] commercialisations per year. In addition, up to 2022, SLINTEC had faced significant challenges, including a notable loss of 80+ scientists over four [04] years and financial constraints affecting operational sustainability. 

Today, the organisation’s remarkable growth highlights its strengthened ability of a newly energised team of scientists led by Dr Perera to convert scientific innovations into practical, market-ready solutions. 

Speaking with Chairman, SLINTEC – Mr Thilan Wijesinghe noted: “SLINTEC’s revenue in 2024 reached a record high and is poised to be eclipsed in 2025. At present, SLINTEC is the only research-based institution that does not rely on Government funding for recurring expenses. An institution with 50% shareholding by the National Science Foundation and 50% by private sector companies such as MAS, LOLC, Brandix and Hayleys, SLINTEC now serves as a model for public-private collaboration in advancing scientific innovation in Sri Lanka.”

The organisation’s commitment to sustainability is demonstrated through R&D focused on natural dyes – a strategy adopted to position SLINTEC as a global leader in this area and to assist growth and innovation in Sri Lanka’s apparel industry. In this regard, two [02] patents have already been commercialised including coconut husk and palm oil waste-based natural dyes, as well as a patent based on packaging material made using agricultural waste such as corn husk.

Commenting on the success of the organisation, CEO, SLINTEC – Dr. Thushara Perera stated: “It is our vision to make SLINTEC Sri Lanka’s most valuable science-based asset through structured commercialisation of R&D. We hope to drive SLINTEC to become a hub for cutting-edge research and sustainability-driven innovation while forging impactful partnerships with industry, local and international universities and R&D establishments, covering a multititle of sectors such as minerals, agriculture and export manufacturing.”

LEAVE A REPLY

Please enter your comment!
Please enter your name here